Board Meeting30 Oct 2026, 02:40 pm
AstraZeneca Pharma India Board Meeting on Nov 5 to Approve Q2 FY27 Results
AI Summary
AstraZeneca Pharma India Ltd has announced that its Board of Directors will convene on Thursday, November 5, 2026. The primary agenda item for this meeting is to consider and approve the un-audited financial results for the quarter and half-year ended September 30, 2026. Concurrently, the company has confirmed that the trading window for designated persons will remain closed from September 16, 2026, to November 7, 2026, in accordance with SEBI (Prohibition of Insider Trading) Regulations.
Key Highlights
- Board meeting scheduled for November 5, 2026.
- To approve un-audited financial results for Q2 FY27.
- Trading window closure from September 16 to November 7, 2026.
- Compliance with SEBI Insider Trading Regulations confirmed.
Price Impact
More from ASTRAZEN